跳至主要内容
临床试验/JPRN-UMIN000010830
JPRN-UMIN000010830已完成未知

Trazenta Randomized study for USing insulin patient of Type 2 Diabetes - TRUST2

Japan society for Patient Reported Outcome0 个研究点目标入组 244 人开始时间: 2013年5月29日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
244

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 80years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • Person who correspond to any of following are excluded: 1.Patients who are Type I or Secondary diabetic mellitus 2.Patients who are treating with Insulin, more than 1 I.U/kg per day 3.Patients who are treating with two or more types of Insulin 4.Patients who are treating with CSII (Continuous Subcutaneous Insulin Infusion) 5.Patients who are treating with DPP-4 Inhibitor, GLP-1 and Alpha-GI at the time of study initiation 6.Patients who are severe infectious disease, perioperative, and severe trauma 7.Patients with myocardial infarction, angina pectoris, cerebral stroke, or cerebral infarction 8.Patients with severe liver dysfunction ( AST:100 IU/l or higher) 9.Patients with moderate or severer heart failure (NYHA/New York Heart Association stage 3 or severer) 10.Patients who require dialysis. 11.Patients who are pregnant, lactating, and possibly pregnant women and those planning to become pregnant 12.Patients with a history of hypersensitivity to investigational drugs. 13.Patients with cancer 14.Patients who receive steroid therapy with inflammatory affection 15.Patients whom doctor judges as ineligible to this study

研究者

发起方
Japan society for Patient Reported Outcome

相似试验